BREDA, SILVIA
 Distribuzione geografica
Continente #
AS - Asia 80
NA - Nord America 79
EU - Europa 58
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 222
Nazione #
US - Stati Uniti d'America 79
CN - Cina 37
IE - Irlanda 23
SG - Singapore 19
HK - Hong Kong 13
DE - Germania 12
FI - Finlandia 7
RU - Federazione Russa 7
VN - Vietnam 7
BR - Brasile 3
BE - Belgio 2
GB - Regno Unito 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BD - Bangladesh 1
CO - Colombia 1
ES - Italia 1
FR - Francia 1
IN - India 1
IT - Italia 1
KR - Corea 1
NL - Olanda 1
TR - Turchia 1
Totale 222
Città #
Dublin 23
Hong Kong 13
Chandler 12
Beijing 10
Singapore 9
Ashburn 8
Jacksonville 7
Los Angeles 6
Dallas 5
Munich 5
Helsinki 4
Ho Chi Minh City 4
Nanchang 4
Boardman 3
Falkenstein 3
Hebei 3
Lawrence 3
Medford 3
Nanjing 3
Princeton 3
Shanghai 3
Wilmington 3
Ann Arbor 2
Brussels 2
Changsha 2
San Francisco 2
Amsterdam 1
Bangalore 1
Columbus 1
Fairfield 1
Hangzhou 1
Hope Mills 1
Jiaxing 1
London 1
Maicao 1
Mcallen 1
Ningbo 1
Nuremberg 1
Pavia 1
Quận Hai 1
Redondo Beach 1
Rio de Janeiro 1
Roubaix 1
Santa Clara 1
Seattle 1
Seoul 1
Shenyang 1
São Paulo 1
The Dalles 1
Thái Nguyên 1
Tianjin 1
Tupaciguara 1
Turku 1
Vienna 1
Woodbridge 1
Xingtai 1
Đồng Nai Province 1
Totale 176
Nome #
Imatinib-loaded gold nanoparticles inhibit proliferation of fibroblasts and macrophages from systemic sclerosis patients and ameliorate experimental bleomycin-induced lung fibrosis 86
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs 82
Switching from intravenous to subcutaneous formulation of abatacept: Different results in a series of 21 patients 63
Totale 231
Categoria #
all - tutte 1.176
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.176


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 1 0 3 1 2 0 0
2021/202214 0 0 0 0 0 0 0 1 2 0 1 10
2022/202343 4 4 1 0 1 5 0 3 25 0 0 0
2023/202420 5 4 0 0 1 3 0 3 1 2 1 0
2024/202556 2 3 1 3 0 5 0 5 13 1 5 18
2025/202652 11 5 11 7 18 0 0 0 0 0 0 0
Totale 231